Agentix Corp.

AGTX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Assets
Cash & Equivalents $771 $4.5K $6.5K $12.4K $145 $1.8K $242.8K —
Accounts Receivable — — — — — — — —
Inventory — — — — $0 $49.4K $0 —
Total Current Assets $771 $100.3K $106.4K $261.4K $16.0K $51.2K $292.8K $93
Property, Plant & Equipment — — — — — — — —
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $771 $100.3K $106.4K $261.4K $16.0K $51.2K $292.8K $93
Liabilities
Accounts Payable $715.9K $968.9K $961.7K $1.1M $145.1K $121.2K $41.3K $7.2K
Total Current Liabilities $3.6M $3.2M $2.7M $2.5M $1.1M $606.9K $69.3K $40.9K
Long-Term Debt — — — — — — — $85.0K
Total Liabilities $3.6M $3.2M $2.7M $2.5M $1.1M $606.9K $69.3K $125.9K
Stockholders' Equity
Retained Earnings $-7.0M $-6.5M $-6.0M $-5.4M $-4.0M $-1.7M $-363.9K $-44.0M
Total Stockholders' Equity $-3.6M $-3.1M $-2.6M $-2.2M $-1.1M $-555.7K $6.7K $-125.8K
← Newer Page 1 of 2 Older →